Formulation of Modified Liquid-Solid Compact for Dissolution Enhancement of Raloxifene Hydrochloride.
Raloxifene hydrochloride (RLX), used in postmenopausal osteoporosis, is a class-II drug as per Biopharmaceutics Classification System. The purpose of this research was to formulate modified liquisolid compacts (MLSC) of RLX for improved dissolution in immediate-release tablet formulations. Prelimina...
| Publicado en: | Pharmaceutical Technology Europe Vol. 33; no. 7; pp. 20 - 25 |
|---|---|
| Autores principales: | , , , |
| Formato: | Journal Article |
| Publicado: |
MJH Life Sciences
Jul2021
|
| Acceso en línea: | Ver este registro en EBSCOhost |